Beximco Pharmaceuticals PLC. (DSE: BXPHARMA)
Health Care · Pharmaceuticals · BD
Tk144.60
+1.40% today · +27.0% 1Y
Beximco Pharmaceuticals PLC. (DSE: BXPHARMA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $523.77M.
Over the last twelve months the share price has gained 27.0%, trading between 99.50 and 158.50.
Tweenvest scores Beximco Pharmaceuticals PLC. across four factors: quality 86/100, value 72/100, growth 50/100, dividend 90/100. Its strongest factor is dividend.
BXPHARMA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $523.77M
- Revenue (TTM)
- $439.75M
- P/E
- 7.46
- EPS
- 19.39
- Dividend yield
- 3.28%
- Beta (5Y)
- 0.30
- 52-week high
- Tk158.50
- 52-week low
- Tk99.50
- Avg volume (3M)
- —
- Shares outstanding
- 446.11M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Zeria Pharmaceutical Co., Ltd.TSE: 4559 | $535.89M | ¥1,925.00 | +1.42% |
| Ocumension TherapeuticsSEHK: 1477 | $527.82M | HK$5.08 | -0.39% |
| GlaxoSmithKline S.A.ECASE: BIOC | $526.26M | EGP330.00 | -5.74% |
| Pulike Biological Engineering, Inc.SHSE: 603566 | $525.28M | CN¥10.29 | +0.49% |
| Evonile Pharma LimitedBSE: 500672 | $522.37M | Rs2,047.55 | +4.05% |
| Tilray Brands, Inc.NasdaqGS: TLRY | $519.19M | $3.38 | -4.66% |
| Shandong Sinobioway Biomedicine Co., Ltd.SZSE: 002581 | $516.12M | CN¥5.24 | +2.75% |
| Orchid Pharma LimitedNSEI: ORCHPHARMA | $515.65M | Rs983.95 | -0.61% |
Figures last refreshed Oct 11, 2026.